{"slideshow_credits": null, "snippet": "Otsuka said it would pay $17 a share in cash for Avanir, a California-based developer of treatments for Alzheimer\u2019s, Parkinson\u2019s and other neurological diseases.", "abstract": "Otsuka said it would pay $17 a share in cash for Avanir, a California-based developer of treatments for Alzheimer\u2019s, Parkinson\u2019s and other neurological diseases.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Jonathan", "role": "reported", "lastname": "SOBLE", "rank": 1, "organization": ""}], "original": "By JONATHAN SOBLE"}, "web_url": "http://dealbook.nytimes.com/2014/12/02/otsuka-of-japan-to-buy-avanir-pharmaceuticals-for-3-5-billion/", "lead_paragraph": null, "headline": {"main": "Otsuka of Japan to Buy Avanir Pharmaceuticals for $3.5 Billion", "kicker": "DealBook"}, "_id": "547da96b38f0d822abda2941", "word_count": "293", "multimedia": [{"height": 126, "url": "images/2014/12/03/business/dbpix-avanir/dbpix-avanir-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/12/03/business/dbpix-avanir/dbpix-avanir-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 397, "url": "images/2014/12/03/business/dbpix-avanir/dbpix-avanir-articleLarge.jpg", "legacy": {"xlarge": "images/2014/12/03/business/dbpix-avanir/dbpix-avanir-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "397"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/12/03/business/dbpix-avanir/dbpix-avanir-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/12/03/business/dbpix-avanir/dbpix-avanir-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-12-02T06:56:57Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "AVANIR Pharmaceuticals", "name": "organizations", "rank": "1"}, {"value": "Otsuka Holdings Co Ltd", "name": "organizations", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "1"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "2"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}